Literature DB >> 20656973

Use of Saccharomyces cerevisiae fermentation product on growth performance and microbiota of weaned pigs during Salmonella infection.

K L Price1, H R Totty, H B Lee, M D Utt, G E Fitzner, I Yoon, M A Ponder, J Escobar.   

Abstract

Anaerobically fermented yeast products are a rich source of nutritional metabolites, mannanoligosaccharides, and β-glucans that may optimize gut health and immunity, which can translate into better growth performance and a reduced risk of foodborne pathogens. The objective of this study was to quantify the effects of Saccharomyces cerevisiae fermentation product (Diamond V Original XPC) inclusion in nursery diets on pig performance and gastrointestinal microbial ecology before, during, and after an oral challenge with Salmonella. Pigs (n = 40) were weaned at 21 d of age, blocked by BW, and assigned in a 2 × 2 factorial arrangement consisting of diet (control or 0.2% XPC) and inoculation (sterile broth or Salmonella). Pigs were fed a 3-phase nursery diet (0 to 7 d, 7 to 21 d, and 21 to 35 d) with ad libitum access to water and feed. On d 14, pigs were orally inoculated with 10(9) cfu of Salmonella enterica serovar Typhimurium DT104 or sterile broth. During d 17 to 20, all pigs were treated with a 5 mg/kg of BW intramuscular injection of ceftiofur-HCl. Growth performance and alterations in the gastrointestinal microbial ecology were measured during preinoculation (PRE; 0 to 14 d), sick (SCK; 14 to 21 d), and postinoculation (POST; 21 to 35 d). Body weight and ADG were measured weekly. Rectal temperature (RT) was measured weekly during PRE and POST, and every 12 h during SCK. Diet had no effect on BW, ADG, or RT during any period (P = 0.12 to 0.95). Inclusion of XPC tended (P < 0.10) to increase Salmonella shedding in feces during SCK. Consumption of XPC altered the composition of the gastrointestinal microbial community, resulting in increased (P < 0.05) populations of Bacteroidetes and Lactobacillus after Salmonella infection. Pigs inoculated with Salmonella had decreased ADG and BW, and increased RT during SCK (P < 0.001). Furthermore, fecal Salmonella cfu (log(10)) was modestly correlated (P = 0.002) with BW (r = -0.22), ADFI (r = -0.27), ADG (r = -0.36), G:F (r = -0.18), and RT (r = 0.52) during SCK. After antibiotic administration, all Salmonella-infected pigs stopped shedding. During POST, an interaction between diet and inoculation (P = 0.009) on ADG indicated that pigs infected with Salmonella grew better when eating XPC than the control diet. The addition of XPC to the diets of weanling pigs resulted in greater compensatory BW gains after infection with Salmonella than in pigs fed conventional nursery diets. This increase in BW gain is likely associated with an increase in beneficial bacteria within the gastrointestinal tract.

Entities:  

Mesh:

Year:  2010        PMID: 20656973     DOI: 10.2527/jas.2009-2728

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  17 in total

1.  Intestinal and systemic immune development and response to vaccination are unaffected by dietary (1,3/1,6)-β-D-glucan supplementation in neonatal piglets.

Authors:  Shelly N Hester; Sarah S Comstock; Shannon C Thorum; Marcia H Monaco; Brandt D Pence; Jeffrey A Woods; Sharon M Donovan
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

2.  Functional amino acid supplementation, regardless of dietary protein content, improves growth performance and immune status of weaned pigs challenged with Salmonella Typhimurium.

Authors:  Lucas A Rodrigues; Michael O Wellington; J Caroline González-Vega; John K Htoo; Andrew G Van Kessel; Daniel A Columbus
Journal:  J Anim Sci       Date:  2021-02-01       Impact factor: 3.159

3.  Energy dense, protein restricted diet increases adiposity and perturbs metabolism in young, genetically lean pigs.

Authors:  Kimberly D Fisher; Tracy L Scheffler; Steven C Kasten; Brad M Reinholt; Gregory R van Eyk; Jeffery Escobar; Jason M Scheffler; David E Gerrard
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

4.  Original XPCTM Effect on Salmonella Typhimurium and Cecal Microbiota from Three Different Ages of Broiler Chickens When Incubated in an Anaerobic In Vitro Culture System.

Authors:  Si Hong Park; Sun Ae Kim; Sang In Lee; Peter M Rubinelli; Stephanie M Roto; Hilary O Pavlidis; Donald R McIntyre; Steven C Ricke
Journal:  Front Microbiol       Date:  2017-06-13       Impact factor: 5.640

5.  Effect of live yeast Saccharomyces cerevisiae (Actisaf Sc 47) supplementation on the performance and hindgut microbiota composition of weanling pigs.

Authors:  T G Kiros; H Derakhshani; E Pinloche; R D'Inca; Jason Marshall; E Auclair; E Khafipour; A Van Kessel
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

6.  Oligosaccharide structure determines prebiotic role of β-galactomannan against Salmonella enterica ser. Typhimurium in vitro.

Authors:  Roger Badia; Rosil Lizardo; Paz Martinez; Joaquim Brufau
Journal:  Gut Microbes       Date:  2012-11-08

Review 7.  An Introduction to the Avian Gut Microbiota and the Effects of Yeast-Based Prebiotic-Type Compounds as Potential Feed Additives.

Authors:  Stephanie M Roto; Peter M Rubinelli; Steven C Ricke
Journal:  Front Vet Sci       Date:  2015-09-02

8.  Fibre digestibility, abundance of faecal bacteria and plasma acetate concentrations in overweight adult mares.

Authors:  Megan L Shepherd; Monica A Ponder; Amy O Burk; Stewart C Milton; William S Swecker
Journal:  J Nutr Sci       Date:  2014-05-07

9.  Analysis of the duodenal microbiotas of weaned piglet fed with epidermal growth factor-expressed Saccharomyces cerevisiae.

Authors:  Zhongwei Zhang; Lili Cao; Yan Zhou; Shujin Wang; Lin Zhou
Journal:  BMC Microbiol       Date:  2016-07-28       Impact factor: 3.605

10.  Inhibition of the virulence, antibiotic resistance, and fecal shedding of multiple antibiotic-resistant Salmonella Typhimurium in broilers fed Original XPC™.

Authors:  K M Feye; K L Anderson; M F Scott; D R McIntyre; S A Carlson
Journal:  Poult Sci       Date:  2016-08-26       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.